metyrapone has been researched along with Infections, Coronavirus in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Newell-Price, J | 1 |
Nieman, LK | 1 |
Reincke, M | 1 |
Tabarin, A | 1 |
Beretta, F | 1 |
Dassie, F | 1 |
Parolin, M | 1 |
Boscari, F | 1 |
Barbot, M | 1 |
Busetto, L | 1 |
Mioni, R | 1 |
De Carlo, E | 1 |
Scaroni, C | 1 |
Fallo, F | 1 |
Vettor, R | 1 |
Maffei, P | 1 |
2 other studies available for metyrapone and Infections, Coronavirus
Article | Year |
---|---|
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome.
Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Coronavirus Infections; | 2020 |
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report.
Topics: Aged; Anti-Inflammatory Agents; Antimetabolites; Betacoronavirus; Coronavirus Infections; COVID-19; | 2020 |